Javascript is required for this site to function, please enable.
Page: Your Opinions About Pharma Support of Possible Future Healthcare Scenarios
1. Please rank each of the following different future scenarios, which were described in the introductory page of this survey, in terms of overall benefit to the pharmaceutical industry. You can select only ONE box in each column and row.
 answered question18
 
skipped question
11
 Least BenefitMost BenefitRating
Average
Rating
Count
The Triumph of Reason0.0% (0)5.9% (1)17.6% (3)41.2% (7)35.3% (6)4.0617
Big Brother Arrives52.9% (9)29.4% (5)5.9% (1)11.8% (2)0.0% (0)1.7617
Consumer Chaos31.3% (5)43.8% (7)18.8% (3)0.0% (0)6.3% (1)2.0616
Safety Net0.0% (0)11.8% (2)41.2% (7)41.2% (7)5.9% (1)3.4117
PhRMA's Platform18.8% (3)6.3% (1)18.8% (3)6.3% (1)50.0% (8)3.6316
Please explain your reasons here:
[ShowReplies]
7

2. Now please indicate how likely or unlikely you believe they will unfold over the next decade in the US IF THE PHARMACEUTICAL INDUSTRY REMAINS ON THE SIDELINES OR NEUTRAL.
 answered question18
 
skipped question
11
 Very LikelySomewhat LikelyNo Opinion/NeutralSomewhat UnlikelyVery UnlikelyRating
Average
Rating
Count
The Triumph of Reason22.2% (4)27.8% (5)16.7% (3)27.8% (5)5.6% (1)0.3318
Big Brother Arrives22.2% (4)33.3% (6)16.7% (3)11.1% (2)16.7% (3)0.3318
Consumer Chaos5.6% (1)16.7% (3)27.8% (5)22.2% (4)27.8% (5)-0.5018
Safety Net11.1% (2)55.6% (10)16.7% (3)11.1% (2)5.6% (1)0.5618
PhRMA's Platform5.6% (1)11.1% (2)16.7% (3)44.4% (8)22.2% (4)-0.6718
Please feel free to add your comments here, especially if you think some OTHER scenario, not mentioned here, is likely or desirable.
[ShowReplies]
2

3. OPTIONAL: Please indicate your level of agreement or disagreement with the following statements regarding "Comparative-Effectiveness" Research (CER).
 answered question13
 
skipped question
16
 Strongly AgreeSomewhat AgreeNeither Agree nor DisagreeSomewhat DisagreeStrongly DisagreeRating
Average
Rating
Count
CER will lower drug costs23.1% (3)61.5% (8)7.7% (1)0.0% (0)7.7% (1)0.9213
CER will lead to European-style rationing in which patients are denied lifesaving therapies to save money7.7% (1)15.4% (2)38.5% (5)7.7% (1)30.8% (4)-0.3813
CER is bound to reduce brand drug companies' bottom lines23.1% (3)38.5% (5)30.8% (4)7.7% (1)0.0% (0)0.7713
CER will lead to better healthcare outcomes16.7% (2)33.3% (4)16.7% (2)25.0% (3)8.3% (1)0.2512
CER will not take into account that some drugs work better on some people than on others38.5% (5)23.1% (3)7.7% (1)23.1% (3)7.7% (1)0.6213
CER based on real-time outcomes review will help identify drug safety issues and save lives30.8% (4)46.2% (6)15.4% (2)0.0% (0)7.7% (1)0.9213
The only real threat of CER is to have it done badly, by people whose only interest is in reducing costs15.4% (2)38.5% (5)15.4% (2)15.4% (2)15.4% (2)0.2313
Add your comments here:
[ShowReplies]
3

4. OPTIONAL BONUS QUESTION: Should Congress Create a Government-Run Health Plan?
 answered question14
 
skipped question
15
 Response
Percent
Response
Count
Definitely
28.6%4
Maybe, depends on the details
21.4%3
Probably not
7.1%1
No way
42.9%6
No opinion 0.0%0
Please explain your reasons here:
[ShowReplies]
3

Page: Questions About You
5. Which best describes your professional or organizational affiliation (please pick only one even if more than one applies):
 answered question29
 
skipped question
0
 Response
Percent
Response
Count
Consumer, consumer advocate, patient, or other non-industry aligned member of the public
6.9%2
BRAND pharmaceutical, biotech, or drug device company employee
24.1%7
GENERIC pharmaceutical, biotech, or drug device company employee 0.0%0
Physician, nurse, other healthcare professional (currently practicing or retired) or medical student
6.9%2
Employed at a marketing/marketing research/advertising/communications agency/company/consultancy having pharmaceutical companies as clients
37.9%11
Current or former FDA or other government health agency employee or staffer 0.0%0
Academic (teacher/professor/non-medical student)
10.3%3
Publishing/Media/Blogger
6.9%2
Other (please describe)
[ShowReplies]
6.9%2

6. Please indicate how supportive you are of the pharmaceutical industry in general.
 answered question29
 
skipped question
0
 Very SupportiveSomewhat SupportiveNeutralSomewhat Unsupportivevery UnsupportiveRating
Average
Rating
Count
In general, I am:55.2% (16)24.1% (7)10.3% (3)0.0% (0)10.3% (3)1.1429

7. Are you a resident of the United States?
 answered question29
 
skipped question
0
 Response
Percent
Response
Count
Yes
79.3%23
No
20.7%6

Page: Opt In Choice
8. OPTIONAL: If your comments are quoted in Pharma Marketing News and you would like attribution, please provide the following information. We will contact you about your comments and give you a chance to approve quotes before they are published. You must supply all contact information, including your email address, for us to do this. This information is NOT shared with third parties and will only be used to contact you about your responses to this survey. LEAVE THIS BLANK IF YOU WISH TO REMAIN ANONYMOUS.
 answered question3
 
skipped question
26
 Response
Percent
Response
Count
Name
[ShowReplies]
100.0%3
Job Title
[ShowReplies]
66.7%2
Company
[ShowReplies]
33.3%1
Phone
[ShowReplies]
33.3%1
E-mail Address
[ShowReplies]
66.7%2

Find...
Show replies
Hide replies